Beta2-adrenoceptor regulation of the K+ channel iKCa1 in human mast cells

S Mark Duffy1, Glenn Cruse, Wendy J Lawley

  • 1Department of Infection, Immunity and Inflammation, University of Leicester, Leicester, UK.

Insights

Beta2-adrenoceptor agonists like salbutamol close the iKCa1 channel in human mast cells, reducing their activation. This occurs via a G protein-coupled receptor mechanism, explaining the stabilizing effect of these common asthma medications.

Area of Science:

  • Immunology
  • Cell Biology
  • Pharmacology

Background:

  • Human mast cells possess the iKCa1 channel, crucial for IgE-dependent activation, Ca2+ influx, and degranulation.
  • Beta2-adrenoceptor agonists, such as salbutamol, are known to attenuate mast cell activation, a process previously attributed to cyclic AMP.
  • The precise molecular mechanism underlying beta2-agonist effects on mast cells remained unclear.

Purpose of the Study:

  • To investigate the effect of salbutamol on the iKCa1 channel in human mast cells.
  • To elucidate the signaling pathway involved in beta2-adrenergic regulation of iKCa1.
  • To provide a molecular mechanism for the mast cell stabilizing effects of beta2-agonists.

Main Methods:

  • Electrophysiological recordings of iKCa1 currents in human lung and peripheral blood-derived mast cells.
  • Pharmacological manipulation using salbutamol, 1-EBIO, ICI 118551, and modulators of cAMP, Galphai, and Galphas.
  • Assessment of mast cell activation markers following anti-IgE stimulation.

Main Results:

  • Salbutamol was found to inhibit iKCa1 currents in activated human mast cells.
  • The beta2-adrenergic antagonist ICI 118551 reversed salbutamol's effect and also opened iKCa1 in quiescent cells, indicating constitutive beta2-receptor signaling.
  • Signaling involved a membrane-delimited pathway mediated by Galphas, independent of intracellular cAMP levels.

Conclusions:

  • Gating of the iKCa1 channel in human mast cells is directly regulated by G protein-coupled receptors, specifically the beta2-adrenoceptor.
  • This study defines a novel mechanism for the mast cell stabilizing effect of beta2-agonists.
  • Constitutive beta2-receptor activity influences the threshold for human mast cell activation via iKCa1 regulation.

Related Concept Videos

Adrenergic Receptors: β Subtype01:26

Adrenergic Receptors: β Subtype

β-adrenoceptors have varied sensitivities towards adrenaline, noradrenaline, and isoprenaline. The order of agonist potency is as follows:
Isoprenaline > Adrenaline > Noradrenaline
Neurotransmitter binding to these receptors causes activation of adenylyl cyclase resulting in increased concentrations of cAMP and modulation of calcium ion channels within the cell. They are further classified into β1, β2, and β3 subtypes.
β1-adrenoceptors: β1-adrenoceptors have equal affinities for...
G-Protein Gated Ion Channels01:21

G-Protein Gated Ion Channels

GPCRs are primarily responsible for our sense of smell, taste, and vision.  The binding of a sensory stimulus activates GPCR to stimulate effector proteins, many of which are ion channels in the sensory organs. GPCRs modulate the opening and closing of the target ion channels either directly by binding them, or by releasing second messengers that activate these channels. As ions move across the membrane, the membrane potential is altered, which induces an appropriate response.
Sensory organs,...
GPCRs Regulate Adenylyl Cylase Activity01:09

GPCRs Regulate Adenylyl Cylase Activity

Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of cells.
Two...
Calmodulin-dependent Signaling01:16

Calmodulin-dependent Signaling

Calmodulin (CaM) is a calcium-binding protein in eukaryotes that controls various calcium-regulated cellular processes. It has four calcium-binding sites that bind calcium to form the calcium-calmodulin ( Ca2+-CaM) complex. GPCR stimulation increases the calcium levels in the cells that bind to CaM and induces a conformational change.
The Ca2+-CaM complex does not have enzymatic activity by itself. Instead, the complex binds downstream target proteins, including membrane proteins or enzymes,...
Antihypertensive Drugs: Action of Calcium Channel Blockers01:18

Antihypertensive Drugs: Action of Calcium Channel Blockers

Calcium ions are essential to contract smooth muscle cells in blood vessels. They enter these cells through voltage-dependent calcium channels, specifically L-type calcium channels in the cell membrane. These L-type calcium channels are integral to the excitation-contraction coupling process in smooth muscle. When a stimulus is received by smooth muscle cells, their membrane depolarizes. This alteration in membrane potential instigates the opening of L-type calcium channels. As a result,...
cAMP-dependent Protein Kinase Pathways01:25

cAMP-dependent Protein Kinase Pathways

Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...